Top

Published in:

01-03-2014 | Review Article

Current status of pelvic lymph node dissection in prostate cancer

Authors: Ilija Aleksic, Tyler Luthringer, Vladimir Mouraviev, David M. Albala

Published in: Journal of Robotic Surgery | Issue 1/2014

Abstract

Pelvic lymph node dissection (PLND) is presently considered the gold standard for the detection of lymph node invasion in prostate cancer (PCa) patients. Controversy exists over the adequate extent of PLND for patients at different stages of PCa and over the therapeutic value of the procedure. The most recent consensus advocates extended PLND (ePLND) in a patient with Gleason score ≥7 and serum prostate-specific antigen >10 ng/ml who is undergoing radical prostatectomy. Critics claim more aggressive dissection is associated with an increase in complications, hospitalization time, and cost. The present review examines the debate of limited versus ePLND, and discusses the potential value of the latter for patients with PCa. Furthermore, it examines the utility of robotic-assisted surgery in performing PLNDs with both comparable oncological outcomes and comparable complication rates. The literature has reported promising results that support both diagnostic and therapeutic benefits of ePLND. However, prospective, multi-center, long-term studies are necessary to alleviate criticism of the increased risk of complications and costs of performing PLND.

Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE (2009) Pelvic lymph node dissection in prostate cancer. Eur Urol 55(6):1251–1265PubMedCrossRef

Autorino R, Stein RJ (2009) The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience. Can J Urol 16(5):4846PubMed

Albala DM, Kevwitch MK, Waters WB (1993) Treatment of persistent lymphatic drainage after laparoscopic pelvic lymph node dissection and radical retropubic prostatectomy. J Endourol 7(4):337–340PubMedCrossRef

Katz S, Rosen M (2006) MR imaging and MR spectroscopy in prostate cancer management. Radiol Clin North Am 44(5):723–734PubMedCrossRef

Fortuin A, Rooij M, Zamecnik P, Haberkorn U, Barentsz J (2013) Molecular and functional imaging for detection of lymph node metastases in prostate cancer. Int J Mol Sci 14(7):13842–13875PubMedCentralPubMedCrossRef

Meijer HJ, Debats OA, van Lin EN, Witjes JA, Kaanders JH, Barentsz JO (2013) A retrospective analysis of the prognosis of prostate cancer patients with lymph node involvement on MR lymphography: who might be cured. Radiat Oncol 8(1):190PubMedCentralPubMedCrossRef

Godoy G, von Bodman C, Chade DC, Dillioglugil O, Eastham JA, Fine SW, Scardino PT, Laudone VP (2012) Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series. J Urol 187(6):2082–2086PubMedCrossRef

Dorin RP, Daneshmand S, Lassoff MA, Cai J, Skinner DG, Lieskovsky G (2012) Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era. Urology 79(3):626–631PubMedCrossRef

Touijer K, Fuenzalida RP, Rabbani F, Paparel P, Nogueira L, Cronin AM, Fine SW, Guillonneau B (2011) Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity? BJU Int 108(3):372–377PubMedCrossRef

10.

Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI (2012) Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer. Int J Urol 19(7):645–651PubMedCrossRef

11.

Jung JH, Seo JW, Lim MS, Lee JW, Chung BH, Hong SJ, Song JM, Rha KH (2012) Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer. J Laparoendosc Adv Surg Tech A 22(8):785–790PubMedCrossRef

12.

Touijer KA, Ahallal Y, Guillonneau BD (2012) Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: practice patterns of uro-oncologists in North America. Urol Oncol 31(8):1517–1521PubMedCrossRef

13.

Haese A, Epstein JI, Huland H, Partin AW (2002) Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 95(5):1016–1021PubMedCrossRef

14.

Crawford ED, Batuello JT, Snow P, Gamito EJ, McLeod DG, Partin AW, Stone N, Montie J, Stock R, Lynch J et al (2000) The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma. Cancer 88(9):2105–2109PubMedCrossRef

15.

Winter A, Uphoff J, Henke RP, Wawroschek F (2012) Complete PSA remission without adjuvant therapy after secondary lymph node surgery in selected patients with biochemical relapse after radical prostatectomy and pelvic lymph node dissection. Adv Urol 2012:609612PubMedCentralPubMedCrossRef

16.

Silberstein JL, Vickers AJ, Power NE, Parra RO, Coleman JA, Pinochet R, Touijer KA, Scardino PT, Eastham JA, Laudone VP (2012) Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures. J Endourol 26(6):748–753PubMedCrossRef

17.

Sengupta S, Weerakoon M, Sethi K, Ischia J, Webb DR (2012) Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population. BJU Int 109(Suppl 3):48–51PubMedCrossRef

18.

Sagalovich D, Calaway A, Srivastava A, Sooriakumaran P, Tewari AK (2012) Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes. BJU Int 111(1):85–94PubMedCrossRef

19.

Mazzola C, Savage C, Ahallal Y, Reuter VE, Eastham JA, Scardino PT, Guillonneau B, Touijer KA (2012) Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors. BJU Int 109(9):1323–1328PubMedCrossRef

20.

Abdollah F, Sun M, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Passoni N, Karakiewicz PI, Rigatti P et al (2012) National comprehensive cancer network practice guidelines 2011: need for more accurate recommendations for pelvic lymph node dissection in prostate cancer. J Urol 188(2):423–428PubMedCrossRef

21.

Briganti A, Karakiewicz PI, Chun FK, Gallina A, Salonia A, Zanni G, Valiquette L, Graefen M, Huland H, Rigatti P et al (2007) Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol 51(6):1573–1581PubMedCrossRef

22.

Feifer AH, Elkin EB, Lowrance WT, Denton B, Jacks L, Yee DS, Coleman JA, Laudone VP, Scardino PT, Eastham JA (2011) Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 117(17):3933–3942PubMedCentralPubMedCrossRef

23.

Kazzazi A, Djavan B (2011) Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram. Can J Urol 18(2):5585–5591PubMed

24.

Briganti A, Gallina A, Suardi N, Chun FK, Walz J, Heuer R, Salonia A, Haese A, Perrotte P, Valiquette L et al (2008) A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer. BJU Int 101(5):556–560PubMedCrossRef

25.

Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A et al (2003) A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170(5):1798–1803PubMedCrossRef

26.

Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A et al (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61(3):480–487PubMedCrossRef

27.

NCCN Clinical Practice Guidelines in Oncology (2013) Prostate cancer: 2013 update. Available at http://www.nccn.org/professionals/physician_gts/pdf/prostate.pdf. Accessed August 5

28.

Walz J, Bladou F, Rousseau B, Laroche J, Salem N, Gravis G, Briganti A, Chun FK, Karakiewicz PI, Fournier G (2012) Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection. Urology 79(3):546–551PubMedCrossRef

29.

Hansen J, Rink M, Bianchi M, Kluth LA, Tian Z, Ahyai SA, Shariat SF, Briganti A, Steuber T, Fisch M et al (2012) External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection. Prostate 73(2):211–218PubMedCrossRef

30.

Briganti A, Suardi N, Capogrosso P, Passoni N, Freschi M, di Trapani E, Gallina A, Capitanio U, Abdollah F, Tutolo M et al (2012) Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum. Prostate 72(2):186–192PubMedCrossRef

31.

Joniau S, Van den Bergh L, Lerut E, Deroose CM, Haustermans K, Oyen R, Budiharto T, Ameye F, Bogaerts K, Van Poppel H (2013) Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 63(3):450–458PubMedCrossRef

32.

Mattei A, Fuechsel FG, Bhatta Dhar N, Warncke SH, Thalmann GN, Krause T, Studer UE (2008) The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 53(1):118–125PubMedCrossRef

33.

Van Baelen A, Mottet N, Spahn M, Briganti A, Gontero P, Joniau S (2012) Sense and nonsense of an extended pelvic lymph node dissection in prostate cancer. Adv Urol 2012:983058PubMedCentralPubMed

34.

Briganti A, Chun FK, Salonia A, Gallina A, Farina E, Da Pozzo LF, Rigatti P, Montorsi F, Karakiewicz PI (2006) Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 98(4):788–793PubMedCrossRef

35.

Briganti A, Chun FK, Salonia A, Gallina A, Zanni G, Scattoni V, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI (2007) Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology 69(1):147–151PubMedCrossRef

36.

Liss MA, Palazzi K, Stroup SP, Jabaji R, Raheem OA, Kane CJ (2013) Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy. World J Urol 31(3):481–488PubMedCrossRef

37.

Yuh BE, Ruel NH, Mejia R, Novara G, Wilson TG (2013) Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer. BJU Int 112(1):81–88PubMedCrossRef

38.

Vagnoni V, Schiavina R, Romagnoli D, Borghesi M, Passaretti G, Dababneh H, Concetti S, Martorana G (2012) Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study. Urologia 79(Suppl 19):e141–e146

39.

Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Mollenhauer M, Schuster T, Autenrieth M, Kubler H et al (2013) Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study. Eur Urol. doi:10.1016/j.eururo.2013.02.007

40.

DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML (2005) The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173(4):1121–1125PubMedCrossRef

41.

Masterson TA, Bianco FJ Jr, Vickers AJ, DiBlasio CJ, Fearn PA, Rabbani F, Eastham JA, Scardino PT (2006) The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 175(4):1320–1324 (discussion 1324–1325)PubMedCentralPubMedCrossRef

42.

Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA (2004) No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Urology 63(3):528–531PubMedCrossRef

43.

Heidenreich A, Ohlmann CH, Polyakov S (2007) Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 52(1):29–37PubMedCrossRef

44.

Ji J, Yuan H, Wang L, Hou J (2012) Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study. J Surg Res 178(2):779–784PubMedCrossRef

45.

Joslyn SA, Konety BR (2006) Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68(1):121–125PubMedCrossRef

46.

von Bodman C, Godoy G, Chade DC, Cronin A, Tafe LJ, Fine SW, Laudone V, Scardino PT, Eastham JA (2010) Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol 184(1):143–148CrossRef

47.

Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172(5 Pt 1):1840–1844PubMedCrossRef

48.

Bader P, Burkhard FC, Markwalder R, Studer UE (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169(3):849–854PubMedCrossRef

49.

Sagalovich D, Calaway A, Srivastava A, Sooriakumaran P, Tewari AK (2013) Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes. BJU Int 111(1):85–94PubMedCrossRef

50.

Truesdale MD, Lee DJ, Cheetham PJ, Hruby GW, Turk AT, Badani KK (2010) Assessment of lymph node yield after pelvic lymph node dissection in men with prostate cancer: a comparison between robot-assisted radical prostatectomy and open radical prostatectomy in the modern era. J Endourol 24(7):1055–1060PubMedCrossRef

51.

Zorn KC, Katz MH, Bernstein A, Shikanov SA, Brendler CB, Zagaja GP, Shalhav AL (2009) Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications. Urology 74(2):296–302PubMedCrossRef

52.

Feicke A, Baumgartner M, Talimi S, Schmid DM, Seifert HH, Muntener M, Fatzer M, Sulser T, Strebel RT (2009) Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol 55(4):876–883PubMedCrossRef

Title: Current status of pelvic lymph node dissection in prostate cancer
Authors: Ilija Aleksic
Tyler Luthringer
Vladimir Mouraviev
David M. Albala
Publication date: 01-03-2014
Publisher: Springer London
Published in: Journal of Robotic Surgery / Issue 1/2014
Print ISSN: 1863-2483
Electronic ISSN: 1863-2491
DOI: https://doi.org/10.1007/s11701-013-0439-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Current status of pelvic lymph node dissection in prostate cancer

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy

Transoral robotic study of the vascular anatomy of the head and neck

Robot assisted laparoscopic documentation of endometriosis

Telerobotic contact transscleral cyclophotocoagulation of the ciliary body with the diode laser

Robotic resection of choledochocele in an adult with intracorporeal hepaticojejunostomy and Roux-en-Y anastomosis: encouraging progress for robotic surgical treatment of biliary disease

Nerve-sparing robotic radical hysterectomy: our technique